PHA\u2122(Pulmonary Hypertension Assessment)is a cutting-edge, fully-automated imaging solution designed to help physicians swiftly assess potential right ventricular dilation\u2014a key indicator of pulmonary hypertension. By automatically processing CTPA scans, PHA measures the maximal diameters of both the right and left ventricles and calculates theRV\/LV ratio.The solution generates clear, annotated images highlighting ventricular measurements and delivers a concise summary report with the RV\/LV ratio directly to the patient study inPACS. This streamlined workflow enables clinicians to quickly access critical information, supporting timely, confident decision-making in the assessment and management of pulmonary hypertension.<\/p>
FDA 510(k) Cleared, For Investigational Use Only outside of the United States<\/i><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
![\"Fully](\"https:\/\/4dmedical.com\/us\/wp-content\/uploads\/sites\/2\/2025\/05\/PHA-Pulmonary-Hypertension-Assessment-2-1.gif\")
![\"Physician](\"https:\/\/4dmedical.com\/us\/wp-content\/uploads\/sites\/2\/2025\/05\/PHA.png\")